Enhancing the Pharmaceutical Industry in Emerging Markets

Driven by both public health needs and industrial upgrading, emerging market countries are accelerating the construction of GMP-compliant factories. For nations such as India, Bangladesh, and Laos, building GMP facilities that meet international standards not only ensures the safety of local medicine supply but also enables the pharmaceutical industry to integrate into global markets.

Challenges in Emerging Markets

Incomplete Regulatory Systems: In some countries, regulatory frameworks are not yet fully aligned with international standards, leading to obstacles in the certification process due to insufficient understanding.

Technology and Talent Gaps: Local engineers and managers often lack hands-on GMP experience, making it difficult to independently manage complex validation and audit processes.

Funding and Risk Control: GMP facility construction requires large investments and long project cycles. Without proper planning, projects are vulnerable to cost overruns and delays.

Chiundo’s Solutions

With years of accumulated GMP consulting experience, Chiundo Co., Ltd. offers clients end-to-end, one-stop solutions:

Regulatory Compliance Guidance: Assisting companies in understanding and adhering to international regulations, including WHO, FDA, EMA, and PMDA standards.

Comprehensive Project Management: From site selection, design, and construction to equipment installation, Chiundo provides standardized processes to ensure efficient project execution.

Talent Training and Knowledge Transfer: Through on-site coaching and remote support, the company helps clients build local teams that meet GMP requirements, ensuring long-term sustainability.

The Value of International Collaboration

In its Laos project, Chiundo not only supported factory construction but also facilitated partnerships with research institutions in Japan and India, enabling the facility to function as both a production base and an R&D center. This “consulting + collaboration” model allowed the client to achieve GMP compliance while strengthening brand recognition and international cooperation.

Outlook

Over the next decade, GMP will remain the core standard of the pharmaceutical industry. For emerging market enterprises to secure a place in global competition, it is essential to complete GMP facility construction and obtain international certification as early as possible. Chiundo will continue to leverage its strengths in compliance expertise, extensive experience, and global vision, helping more enterprises enhance their industry capabilities and move toward global development.